Physician

Mark Minh Tran, M.D.

According to 2025 Medicare claims, Mark Tran, M.D. (NPI: 1205098696) practices dermatology in the Anaheim-Santa Ana-Irvine, CA market, with the plurality of this provider's patient population coming from Orange, CA. This provider's primary affiliated billing organization is LEE MD, INC (NPI: 1679971535; TIN: 471144940) and primary practice location at 92625-1912.

Tran's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 535 traditional Medicare patients, billed 41,455 HCPCS/CPT codes, and received $16,412,753 in Medicare payments. The top billing code was 88344 (Special stained specimen slides to examine tissue, each multiplex procedure). Part D data shows 405 prescription claims across 164 beneficiaries totaling $9,063 in drug costs, led by Gentamicin Sulfate (Gentamicin Sulfate). DME data shows 33 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $60,713 to $16,412,753. In contrast, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $216,196 to $9,063. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	163	1,007	$60,713
2017	238	1,574	$100,092
2018	308	2,291	$137,642
2019	444	6,133	$329,016
2020	526	8,117	$575,138
2021	596	24,235	$2,160,500
2022	618	35,451	$3,307,966
2023	533	49,286	$6,465,147
2024	535	41,455	$16,412,753

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	645	1,450	$216,196
2016	79	146	$20,937
2017	58	138	$8,086
2018	70	193	$9,161
2019	118	370	$25,542
2020	154	538	$25,763
2021	138	397	$13,359
2022	190	474	$15,176
2023	173	411	$10,505
2024	164	405	$9,063

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	22	$2,377
2023	N/R	N/R	N/R
2024	N/R	33	$2,756

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
88344	Special stained specimen slides to examine tissue, each multiplex procedure	359	2,707	$171
88360	Microscopic genetic analysis of tumor, manual	324	3,055	$117
88312	Special stained specimen slides to identify organisms including interpretation and report	379	4,394	$110
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	290	543	$109
88305	Pathology examination of tissue using a microscope, intermediate complexity	414	6,932	$68

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gentamicin Sulfate	Gentamicin Sulfate	55	1,324	$1,599
Ciclopirox	Ciclopirox Olamine	72	1,897	$668
Halobetasol Propionate	Halobetasol Propionate	13	375	$631
Mupirocin	Mupirocin	108	2,244	$622
Valacyclovir	Valacyclovir Hcl	12	93	$282

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A6212	Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing	N	N/R	11	$1,371
A6196	Alginate or other fiber gelling dressing, wound cover, sterile, pad size 16 sq. in. or less, each dressing	N	N/R	11	$1,039
A6207	Contact layer, sterile, more than 16 sq. in. but less than or equal to 48 sq. in., each dressing	N	N/R	11	$346

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Mark Minh Tran, M.D.?

Tedicare shows public-source Medicare data for Mark Minh Tran, M.D. (NPI 1205098696), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark Minh Tran, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mark Minh Tran, M.D.?

Mark Minh Tran, M.D. is linked to LEE MD, INC (billing NPI 1679971535) in the available physician profile data.

Does Mark Minh Tran, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.